Key Insights

Highlights

Success Rate

33% trial completion

Treatment Research

13 treatments under study, led by Positron Emission Tomography

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

50.0%

2 terminated out of 4 trials

Success Rate

33.3%

-53.3% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results33% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
Phase 1 (1)
Phase 2 (1)

Trial Status

Terminated2
Completed1
Withdrawn1

Trial Success Rate

33.3%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT01234805Not ApplicableTerminated

Yoga Therapy in Treating Patients With Malignant Brain Tumors

NCT02194452Not ApplicableWithdrawn

Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors

NCT00492089Phase 2Completed

Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

NCT00110032Phase 1Terminated

Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors

Showing all 4 trials

Research Network

Common Treatments

  • Positron Emission Tomography2
  • Qualityoflife Assessment2
  • Ef51
  • Magnetic Resonance Imaging1
  • Questionnaire Administration1

Active Sponsors

  • National Cancer Institute (NCI)4
  • Sue O'Dorisio1
  • Ride for Kids1
  • Wake Forest University Health Sciences1

Top Investigators

Related Conditions

  • Adult Diffuse Astrocytoma4
  • Adult Anaplastic Astrocytoma4
  • Adult Pineocytoma4
  • Adult Ependymoma4
  • Adult Oligodendroglioma4

Activity Timeline